Blogs
From the Proscia blog: For HNL Lab Medicine, digital pathology isn’t just a technology upgrade—it’s a strategic business decision that has already delivered measurable gains. By partnering with Proscia, HNL Lab Medicine has not only...
From the Proscia blog: If you’re a diagnostic laboratory looking to go digital, then you’ve almost certainly thought about how your platform will integrate with your LIS. We sat down with Jacob Blaylock, our Senior Integration Engineer,...
The latest from the Proscia blog In a recent Today’s Clinical Lab webinar, our Chief Strategy Officer Nathan Buchbinder led a discussion on insights stemming from The 2025 Laboratory Leadership Report. He was joined by three of our...
Dr. Lal PathLabs: It accurately detected single-cell and micrometastases that had been missed during manual reviews. Results were later validated through IHC, confirming the system’s reliability Dr. Lal PathLabs (DLPL) has adopted a deep...
The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...
The latest from the Proscia blog: Everyone’s talking about AI in therapeutic R&D, but it’s not always easy to cut through the hype to understand where it’s making a real impact today. One of the clearest signals of progress?...
